Simultaneous detection of 93 conventional and emerging drugs of abuse and their metabolites in urine by UHPLC-MS/MS

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 969, Issue , 2014, Pages 272-284

  Tang, Magdalene H Y ^a   Ching, C K ^a   Lee, Caroline Y W ^a   Lam, Ying Hoo ^a   Mak, Tony W L ^a  

^a PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

Drug screening; Drugs of abuse; LCMS; Novel psychoactive substance; Urine analysis

Indexed keywords

BIOMOLECULES; BODY FLUIDS; CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; PHASE SEPARATION; SPECTROMETRY;

DRUG SCREENING; DRUGS OF ABUSE; LCMS; NOVEL PSYCHOACTIVE SUBSTANCE; URINE ANALYSIS;

DRUG PRODUCTS;

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 3 (1 NAPHTHOYL) 1 PENTYLINDOLE; 4' METHYLMETHCATHINONE; AMOBARBITAL; AMPHETAMINE; CHLORAMPHETAMINE; CHLORDIAZEPOXIDE; DEXTROMETHORPHAN; DIAZEPAM; DRUG METABOLITE; ESTAZOLAM; FLUNITRAZEPAM; ILLICIT DRUG; METHADONE; METHAQUALONE; METHCATHINONE; METHYLONE; MIDAZOLAM; MITRAGYNINE; NIMETAZEPAM; OXAZEPAM; PHENTERMINE; PSYCHOTROPIC AGENT; SALVINORIN A; SECBUTABARBITAL; SECOBARBITAL; TILETAMINE; TRIAZOLAM; UNINDEXED DRUG; ZOLPIDEM; STREET DRUG;

ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG DETERMINATION; ENZYMATIC DEGRADATION; LIMIT OF DETECTION; MEASUREMENT PRECISION; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; CHEMISTRY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; PROCEDURES; REPRODUCIBILITY; SUBSTANCE ABUSE; URINE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; LIMIT OF DETECTION; REPRODUCIBILITY OF RESULTS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84928829565     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2014.08.033     Document Type: Article

References (68)

1. New drugs in Europe, 2012. EMCDDA-Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Europol, 2012.
2. Davis G.G. Clin. Lab. Med. 2012, 32:407-414.
3. Gibbons S. Clin. Toxicol. (Phila.) 2012, 50:15-24.
4. Rosenbaum C.D., Carreiro S.P., Babu K.M. J. Med. Toxicol. 2012, 8:15-32.
5. Lin D.L., Liu H.C., Yin H.L. J. Anal. Toxicol. 2007, 31:109-113.
6. Lurie Y., Gopher A., Lavon O., Almog S., Sulimani L., Bentur Y. Clin. Toxicol. (Phila.) 2012, 50:39-43.
7. Maskell P.D., De Paoli G., Seneviratne C., Pounder D.J., Mephedrone J. Anal. Toxicol. 2011, 35:188-191.
8. Nelson M.E., Bryant S.M., Aks S.E. Emerg. Med. Clin. North Am. 2014, 32:1-28.
9. Prosser J.M., Nelson L.S. J. Med. Toxicol. 2012, 8:33-42.
10. Vevelstad M., Oiestad E.L., Middelkoop G., Hasvold I., Lilleng P., Delaveris G.J., Eggen T., Morland J., Arnestad M., The P.M.M.A. Forensic Sci. Int. 2012, 219:151-157.
11. Petrie M., Lynch K.L., Ekins S., Chang J.S., Goetz R.J., Wu A.H., Krasowski M.D. Clin. Toxicol. (Phila.) 2013, 51:83-91.
12. Stellpflug S.J., Kealey S.E., Hegarty C.B., Janis G.C. J. Med. Toxicol. 2014, 10:45-50.
13. Badawi N., Simonsen K.W., Steentoft A., Bernhoft I.M., Linnet K. Clin. Chem. 2009, 55:2004-2018.
14. Bjork M.K., Nielsen M.K., Markussen L.O., Klinke H.B., Linnet K. Anal. Bioanal. Chem. 2010, 396:2393-2401.
15. Cheng W.C., Yau T.S., Wong M.K., Chan L.P., Mok V.K. Forensic Sci. Int. 2006, 162:95-107.
16. Dowling G., Regan L. J. Pharm. Biomed. Anal. 2011, 54:1136-1145.
17. Feng J., Wang L., Dai I., Harmon T., Bernert J.T. J. Anal. Toxicol. 2007, 31:359-368.
18. Gunnar T., Ariniemi K., Lillsunde P. J. Mass Spectrom. 2005, 40:739-753.
19. Paterson S., Cordero R., McCulloch S., Houldsworth P. Ann. Clin. Biochem. 2000, 37:690-700.
20. Tsai I.L., Weng T.I., Tseng Y.J., Tan H.K., Sun H.J., Kuo C.H. J. Anal. Toxicol. 2013, 37:642-651.
21. Hegstad S., Hermansson S., Betner I., Spigset O., Falch B.M. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2014, 947-948:83-95.
22. Amaratunga P., Lorenz Lemberg B., Lemberg D. J. Anal. Toxicol. 2013, 37:622-628.
23. Ammann D., McLaren J.M., Gerostamoulos D., Beyer J. J. Anal. Toxicol. 2012, 36:381-389.
24. Dresen S., Kneisel S., Weinmann W., Zimmermann R., Auwarter V. J. Mass Spectrom. 2011, 46:163-171.
25. Dziadosz M., Weller J.P., Klintschar M., Teske J. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2013, 929:84-89.
26. Nieddu M., Boatto G., Pirisi M.A., Dessi G. Rapid Commun. Mass Spectrom. 2010, 24:2357-2362.
27. Nordgren H.K., Holmgren P., Liljeberg P., Eriksson N., Beck O. J. Anal. Toxicol. 2005, 29:234-239.
28. Rodrigues W.C., Catbagan P., Rana S., Wang G., Moore C. J. Anal. Toxicol. 2013, 37:526-533.
29. Wohlfarth A., Weinmann W., Dresen S. Anal. Bioanal. Chem. 2010, 396:2403-2414.
30. Apollonio L.G., Whittall I.R., Pianca D.J., Kyd J.M., Maher W.A. Rapid Commun. Mass Spectrom. 2006, 20:2259-2264.
31. Beyer J., Peters F.T., Kraemer T., Maurer H.H. J. Mass Spectrom. 2007, 42:150-160.
32. del Mar Ramirez Fernandez M., Laloup M., Wood M., De Boeck G., Lopez-Rivadulla M., Wallemacq P., Samyn N. J. Anal. Toxicol. 2007, 31:497-504.
33. Forsstrom T., Tuominen J., Karkkainen J. Scand. J. Clin. Lab. Invest. 2001, 61:547-556.
34. Nordgren H.K., Beck O. Ther. Drug Monit. 2004, 26:90-97.
35. O'Byrne P.M., Kavanagh P.V., McNamara S.M., Stokes S.M. J. Anal. Toxicol. 2013, 37:64-73.
36. Pichini S., Pujadas M., Marchei E., Pellegrini M., Fiz J., Pacifici R., Zuccaro P., Farre M., de la Torre R. J. Pharm. Biomed. Anal. 2008, 47:335-342.
37. Quintela O., Sauvage F.L., Charvier F., Gaulier J.M., Lachatre G., Marquet P. Clin. Chem. 2006, 52:1346-1355.
38. Sorensen L.K. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2011, 879:727-736.
39. Vorce S.P., Sklerov J.H. J. Anal. Toxicol. 2004, 28:407-410.
40. Archer J.R., Dargan P.I., Hudson S., Wood D.M. QJM 2013, 106:147-152.
41. Pedersen A.J., Dalsgaard P.W., Rode A.J., Rasmussen B.S., Muller I.B., Johansen S.S., Linnet K. J. Sep. Sci. 2013, 36:2081-2089.
42. [42] Commission decision of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results (2002/657/EC), Official Journal of the European Communities 17.8.2002.
43. [43] Mass Spectrometry in the Clinical Laboratory: General Principles and Guidance; Approved Guideline, Clinical and Laboratory Standards Institute (CLSI), 2007.
44. The fitness for purpose of analytical methods: A laboratory guide to method validation and related topics, EURACHEM Working Group, 1998.
45. Trullols E., Ruisanchez I., Rius F.X. Trends Anal. Chem. 2004, 23:137-145.
46. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 2003, 75:3019-3030.
47. Al-Saffar Y., Stephanson N.N., Beck O. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2013, 930:112-120.
48. Kelly J.P. Drug Test. Anal. 2011, 3:439-453.
49. Yanes E.G., Lovett D.P. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2012, 909:42-50.
50. Baselt R.C. Disposition of Toxic Drugs and Chemicals in Man 2008, Biomedical Publications, Foster City, California.
51. Drummer O.H. J. Chromatogr. B Biomed. Sci. Appl. 1998, 713:201-225.
52. Meyer M.R., Du P., Schuster F., Maurer H.H. J. Mass Spectrom. 2010, 45:1426-1442.
53. Meyer M.R., Wilhelm J., Peters F.T., Maurer H.H. Anal. Bioanal. Chem. 2010, 397:1225-1233.
54. Kamata T., Katagi M., Kamata H.T., Miki A., Shima N., Zaitsu K., Nishikawa M., Tanaka E., Honda K., Tsuchihashi H. Drug Metab. Dispos. 2006, 34:281-287.
55. [55] Heathcontrol drugs of abuse in urine proficiency testing scheme: Scheme description, LGC, Standards, August 2012.
56. Lee Y.W. Clin. Psychopharmacol. Neurosci. 2013, 11:158-164.
57. Corkery J.M., Schifano F., Ghodse A.H. Mephedrone-related fatalities in the United Kingdom: Contextual, clinical and practical issues. Pharmacology 2012, 355-380. InTech. L. Gallelli (Ed.).
58. Vorce S.P., Holler J.M., Levine B., Past M.R. J. Anal. Toxicol. 2008, 32:444-450.
59. Moran C.L., Le V.H., Chimalakonda K.C., Smedley A.L., Lackey F.D., Owen S.N., Kennedy P.D., Endres G.W., Ciske F.L., Kramer J.B., Kornilov A.M., Bratton L.D., Dobrowolski P.J., Wessinger W.D., Fantegrossi W.E., Prather P.L., James L.P., Radominska-Pandya A., Moran J.H. Anal. Chem. 2011, 83:4228-4236.
60. Lin T.C., Lin D.L., Lua A.C. J. Anal. Toxicol. 2011, 35:205-210.
61. de Jager A.D., Warner J.V., Henman M., Ferguson W., Hall A. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2012, 897:22-31.
62. Moller I., Wintermeyer A., Bender K., Jubner M., Thomas A., Krug O., Schanzer W., Thevis M. Drug Test. Anal. 2011, 3:609-620.
63. Sobolevsky T., Prasolov I., Rodchenkov G. Forensic Sci. Int. 2010, 200:141-147.
64. Arbo M.D., Bastos M.L., Carmo H.F. Drug Alcohol Depend. 2012, 122:174-185.
65. Zawilska J.B., Wojcieszak J. Forensic Sci. Int. 2013, 231:42-53.
66. Lee H.K., Ho C.S., Iu Y.P., Lai P.S., Shek C.C., Lo Y.C., Klinke H.B., Wood M. Anal. Chim. Acta 2009, 649:80-90.
67. Wu A.H., Gerona R., Armenian P., French D., Petrie M., Lynch K.L. Clin. Toxicol. (Phila.) 2012, 50:733-742.
68. Helander A., Beck O., Hagerkvist R., Hulten P. Scand. J. Clin. Lab. Invest. 2013, 73:400-406.